 | Cocaine | IC50 | 325.0 [1] |
| Cocaine | Ki | 310.0 [1] |
 | Fluoxetine | IC50 | 9.4 [1] |
| Fluoxetine | Ki | 0.72 [1], 48.0 [2] |
 | Imipramine | IC50 | 5.1 [1] |
| Imipramine | Ki | 5.7 [1], 7.57 [2], 31.0 [3], 1300.0 [4] |
 | Duloxetine | IC50 | 6.0 [1] |
| Duloxetine | Ki | 0.5 [1], 0.8 [2], 4.6 [3], 5.0 [4], 790.0 [5] |
 | Paroxetine | IC50 | 0.2 [1], 0.56 [2], 2.0 [3], 20.0 [4] |
| Paroxetine | Ki | 0.04 [1] |
 | Citalopram | IC50 | 6.27 [1], 6.7 [2], 19.0 [3], 90000.0 [4] |
| Citalopram | Ki | 1.6 [1], 16.0 [2] |
 | Venlafaxine | IC50 | 31.0 [1] |
| Venlafaxine | Ki | 3.81 [1], 39.0 [2] |
 | Atomoxetine | IC50 | 180.0 [1] |
 | 2-[(2-Ethoxyphenoxy)-phenylmethyl]morpholine | IC50 | 242.0 [1] |
| 2-[(2-Ethoxyphenoxy)-phenylmethyl]morpholine | Ki | 9.0 [1], 129.0 [2], 1400.0 [3] |
 | Nisoxetine | IC50 | 700.0 [1] |
| Nisoxetine | Ki | 1.4 [1], 203.0 [2] |
 | Escitalopram | IC50 | 2.1 [1], 10.0 [2], 4600.0 [3] |
| Escitalopram | Ki | 1.0 [1], 1.77 [2], 2.2 [3], 7.4 [4] |
 | Venlafaxine hydrochloride | IC50 | 200.0 [1] |
 | Methyl (1R,2S,3S,5R)-3-(4-fluorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate | IC50 | 160.0 [1], 5060.0 [2] |
| Methyl (1R,2S,3S,5R)-3-(4-fluorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate | Ki | 63.0 [1], 181.0 [2] |
 | Midalcipran | IC50 | 50.12 [1], 100.0 [2], 420.0 [3], 3500.0 [4] |
| Midalcipran | Ki | 6.5 [1] |
 | BMS-505130 free base | IC50 | 0.36 [1], 0.48 [2], 0.56 [3] |
| BMS-505130 free base | Ki | 0.18 [1], 0.56 [2] |
 | 3,4-Methylenedioxymethamphetamine | IC50 | 425.0 [1], 1100.0 [2], 2754.23 [3] |
| 3,4-Methylenedioxymethamphetamine | Ki | 0.73 [1], 2.03 [2] |
 | Mazindol | IC50 | 54.0 [1], 94.0 [2] |
| Mazindol | Ki | 45.0 [1], 50.0 [2], 136.0 [3] |
 | Vanoxerine | IC50 | 73.0 [1], 741.0 [2], 1460.0 [3], 3840.0 [4] |
| Vanoxerine | Ki | 126.0 [1], 130.0 [2] |
 | Madam | Ki | 0.25 [1] |
 | 1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane | IC50 | 13.8 [1], 14.0 [2], 215.0 [3], 723.0 [4] |
| 1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane | Ki | 63.0 [1] |
 | Rel-1-(3,4-dichlorophenyl)-6-(methoxymethyl)-3-azabicyclo[4.1.0]heptane | IC50 | 3.98 [1], 9.2 [2] |
| Rel-1-(3,4-dichlorophenyl)-6-(methoxymethyl)-3-azabicyclo[4.1.0]heptane | Ki | 0.63 [1], 1.05 [2], 1.58 [3] |
 | Bupropion | IC50 | 100.0 [1], 47000.0 [2], 100000.0 [3] |
| Bupropion | Ki | 10000.0 [1] |
 | Desipramine | IC50 | 52.4 [1], 64.0 [2], 108.0 [3], 560.0 [4] |
| Desipramine | Ki | 20.0 [1] |
 | 2-((2-((Dimethylamino)methyl)phenyl)thio)-5-iodophenylamine | Ki | 0.01 [1], 1.07 [2], 840.0 [3] |
 | Methyl 3-(3,4-dichlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate | IC50 | 2.47 [1], 2.5 [2], 27.0 [3], 27.7 [4] |
 | 3-(3-(Dimethylamino)propyl)-1H-indole-5-carbonitrile | IC50 | 2.0 [1] |
| 3-(3-(Dimethylamino)propyl)-1H-indole-5-carbonitrile | Ki | 2.0 [1] |
 | Haloperidol | Ki | 1000.0 [1], 1799.0 [2], 1800.0 [3] |
 | Clozapine | IC50 | 10000.0 [1] |
| Clozapine | Ki | 290.0 [1], 1000.0 [2], 3900.0 [3] |
 | Aripiprazole | Ki | 31.62 [1], 98.0 [2], 240.0 [3], 1080.0 [4] |
 | Nomifensine | IC50 | 8709.64 [1] |
| Nomifensine | Ki | 874.0 [1], 1400.0 [2], 2057.0 [3] |
 | 1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine | IC50 | 289.0 [1], 3710.0 [2] |
| 1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine | Ki | 620.0 [1], 2090.0 [2] |
 | Amitifadine | IC50 | 12.3 [1], 411.5 [2] |
| Amitifadine | Ki | 19.95 [1], 141.25 [2] |
 | 3-(4-Chloro-phenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid methyl ester | IC50 | 5.87 [1], 19.0 [2], 998.0 [3] |
| 3-(4-Chloro-phenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid methyl ester | Ki | 44.5 [1] |
 | 3-(4-Iodo-phenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid methyl ester | IC50 | 4.2 [1] |
| 3-(4-Iodo-phenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid methyl ester | Ki | 0.38 [1], 0.67 [2], 4.2 [3] |
 | (R)-Sila-Venlafaxine | IC50 | 3168.0 [1], 4200.0 [2] |
 | 4-(3,4-Dimethoxy-phenyl)-4a,5,8,8a-tetrahydro-2H-phthalazin-1-one | IC50 | 100000.0 [1] |
| 4-(3,4-Dimethoxy-phenyl)-4a,5,8,8a-tetrahydro-2H-phthalazin-1-one | Ki | 100000.0 [1] |
 | (S)-N-(2,3-Dimethylbenzyl)-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amine | IC50 | 9.0 [1] |
 | 4-(4-Methoxyphenyl)-2-methyl-7-(3-(piperidin-1-yl)propoxy)-1,2,3,4-tetrahydroisoquinoline | Ki | 2.0 [1], 5.1 [2] |
 | (1S,5S,6S)-1-(3,4-Dichlorophenyl)-6-(ethoxymethyl)-3-azabicyclo[3.1.0]hexane | IC50 | 1.26 [1] |
| (1S,5S,6S)-1-(3,4-Dichlorophenyl)-6-(ethoxymethyl)-3-azabicyclo[3.1.0]hexane | Ki | 0.16 [1], 0.4 [2] |
 | 2-[5-[3-(5-Fluoro-2-methoxyphenyl)propyl]oxolan-2-yl]ethanamine | IC50 | 2.3 [1], 7.4 [2] |
| 2-[5-[3-(5-Fluoro-2-methoxyphenyl)propyl]oxolan-2-yl]ethanamine | Ki | 1.1 [1], 7.0 [2] |
 | Dimethyl-((2S,3S)-3-naphthalen-2-yl-bicyclo[2.2.1]hept-2-ylmethyl)-amine | IC50 | 9.0 [1] |
| Dimethyl-((2S,3S)-3-naphthalen-2-yl-bicyclo[2.2.1]hept-2-ylmethyl)-amine | Ki | 2.3 [1] |
 | (R)-3-(4-(Dimethylamino)cyclohex-1-enyl)-1H-indole-5-carbonitrile | IC50 | 0.4 [1], 0.72 [2] |
 | 3-[4-(3,4-Dihydro-1H-isoquinolin-2-yl)-cyclohexyl]-1H-indole-5-carbonitrile | Ki | 4.51 [1], 90.7 [2], 189.0 [3], 286.0 [4] |
 | (cis)-2-(5-Bromopentyl)-4-(3,4-dimethoxyphenyl)-4a,5,8,8a-tetrahydrophthalazin-1(2H)-one | IC50 | 100000.0 [1] |
| (cis)-2-(5-Bromopentyl)-4-(3,4-dimethoxyphenyl)-4a,5,8,8a-tetrahydrophthalazin-1(2H)-one | Ki | 100000.0 [1] |
 | 3-[4-(6-Methoxy-3,4-dihydro-1H-isoquinolin-2-yl)-cyclohexyl]-1H-indole-5-carbonitrile | Ki | 4.1 [1], 73.7 [2], 165.0 [3], 518.0 [4] |
 | N,N-Dimethyl-3-[2-[3-(3-naphthalen-1-yloxypropoxy)prop-1-ynyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]propan-1-amine | IC50 | 940.0 [1] |
| N,N-Dimethyl-3-[2-[3-(3-naphthalen-1-yloxypropoxy)prop-1-ynyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]propan-1-amine | Ki | 1200.0 [1], 3500.0 [2], 27000.0 [3] |
 | N,N-Dimethyl-3-[2-[3-[2-(2-naphthalen-1-ylethoxy)ethoxy]prop-1-ynyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]propan-1-amine | IC50 | 300.0 [1] |
| N,N-Dimethyl-3-[2-[3-[2-(2-naphthalen-1-ylethoxy)ethoxy]prop-1-ynyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]propan-1-amine | Ki | 540.0 [1], 1100.0 [2], 5200.0 [3] |
 | N,N-Dimethyl-3-[2-[3-[2-(2-naphthalen-1-yloxyethoxy)ethoxy]prop-1-ynyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]propan-1-amine | IC50 | 420.0 [1] |
| N,N-Dimethyl-3-[2-[3-[2-(2-naphthalen-1-yloxyethoxy)ethoxy]prop-1-ynyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]propan-1-amine | Ki | 450.0 [1], 6400.0 [2], 6500.0 [3] |
 | N,N-Dimethyl-3-[2-[3-[2-(2-naphthalen-1-ylsulfanylethoxy)ethoxy]prop-1-ynyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]propan-1-amine | IC50 | 560.0 [1] |
| N,N-Dimethyl-3-[2-[3-[2-(2-naphthalen-1-ylsulfanylethoxy)ethoxy]prop-1-ynyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]propan-1-amine | Ki | 500.0 [1], 2000.0 [2], 19000.0 [3] |
 | 3-[2-[3-[3-(5,6-Dihydrobenzo[b][1]benzazepin-11-yl)propoxy]prop-1-ynyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]-N,N-dimethylpropan-1-amine | IC50 | 1600.0 [1] |
| 3-[2-[3-[3-(5,6-Dihydrobenzo[b][1]benzazepin-11-yl)propoxy]prop-1-ynyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]-N,N-dimethylpropan-1-amine | Ki | 1600.0 [1], 13000.0 [2], 16000.0 [3] |
 | N,N-Dimethyl-3-[2-[3-(3-naphthalen-1-yloxypropoxy)propyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]propan-1-amine | IC50 | 600.0 [1] |
| N,N-Dimethyl-3-[2-[3-(3-naphthalen-1-yloxypropoxy)propyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]propan-1-amine | Ki | 620.0 [1], 1200.0 [2], 9400.0 [3] |
 | N,N-Dimethyl-3-[2-[3-(naphthalen-1-ylmethoxy)prop-1-ynyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]propan-1-amine | IC50 | 340.0 [1] |
| N,N-Dimethyl-3-[2-[3-(naphthalen-1-ylmethoxy)prop-1-ynyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]propan-1-amine | Ki | 280.0 [1], 590.0 [2], 5400.0 [3] |
 | N,N-Dimethyl-3-[2-[3-(naphthalen-1-ylmethylsulfanyloxy)prop-1-ynyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]propan-1-amine | IC50 | 350.0 [1] |
| N,N-Dimethyl-3-[2-[3-(naphthalen-1-ylmethylsulfanyloxy)prop-1-ynyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]propan-1-amine | Ki | 475.0 [1], 1100.0 [2], 4700.0 [3] |
 | N,N-Dimethyl-3-[2-[3-[2-(2-naphthalen-1-ylethoxy)ethoxy]propyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]propan-1-amine | IC50 | 280.0 [1] |
| N,N-Dimethyl-3-[2-[3-[2-(2-naphthalen-1-ylethoxy)ethoxy]propyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]propan-1-amine | Ki | 360.0 [1], 1000.0 [2], 6700.0 [3] |
 | 3-[2-[3-[3-(5,6-Dihydrobenzo[b][1]benzazepin-11-yl)propoxy]propyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]-N,N-dimethylpropan-1-amine | IC50 | 270.0 [1] |
| 3-[2-[3-[3-(5,6-Dihydrobenzo[b][1]benzazepin-11-yl)propoxy]propyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]-N,N-dimethylpropan-1-amine | Ki | 330.0 [1], 6300.0 [2], 15000.0 [3] |
 | 3-[2-[3-[3-[3-(5,6-Dihydrobenzo[b][1]benzazepin-11-yl)propoxy]propoxy]propyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]-N,N-dimethylpropan-1-amine | IC50 | 840.0 [1] |
| 3-[2-[3-[3-[3-(5,6-Dihydrobenzo[b][1]benzazepin-11-yl)propoxy]propoxy]propyl]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]-N,N-dimethylpropan-1-amine | Ki | 640.0 [1], 5900.0 [2], 11000.0 [3] |
 | 3-[11-[3-(Dimethylamino)propyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]prop-2-yn-1-ol | IC50 | 60.0 [1] |
Calculator
